Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Genetics, Epigenetics, and Genomics

Abstract CN02-02: Ovarian cancer GWAS: Path from risk assessment to prevention?

Thomas A. Sellers
Thomas A. Sellers
1H. Lee Moffitt Cancer Center, Tampa, FL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1940-6207.PREV-11-CN02-02 Published October 2011
  • Article
  • Info & Metrics
Loading
Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA

Abstract

Ovarian cancer risk is known to be influenced by highly penetrant mutations in BRCA1 and BRCA2. However, these are rare in the population and collectively account for around 10% of cases. Since these genes account for less than 50% of the familial risk of ovarian cancer, other loci must surely exist. Genome wide association studies have contributed to the identification of at least six additional chromosomal regions harboring common genetic variants that are associated with modest levels of risk increase or decrease. The knowledge of Mendelian and oligogenic susceptibility genes lays the foundation for risk-appropriate preventive interventions. Several options have already been identified through epidemiologic research, ranging from relatively innocuous strategies such as use of oral contraceptives, to more invasive surgical approaches such as tubal ligation and oophorectomy, each with varying degrees of effectiveness as well as complication rates and side effects. The level of genetic risk should inform decisions and strategies as to the appropriate intervention. However, there is a need for less invasive prevention strategies, especially chemoprevention. Finally, more progress is needed in the translation and dissemination of risk assessment to risk reduction in the clinical practice and public health settings.

Citation Information: Cancer Prev Res 2011;4(10 Suppl):CN02-02.

  • Copyright © American Association for Cancer Research
Previous
Back to top
Cancer Prevention Research: 4 (10 Supplement)
October 2011
Volume 4, Issue 10 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract CN02-02: Ovarian cancer GWAS: Path from risk assessment to prevention?
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
Citation Tools
Abstract CN02-02: Ovarian cancer GWAS: Path from risk assessment to prevention?
Thomas A. Sellers
Cancer Prev Res October 1 2011 (4) (10 Supplement) CN02-02; DOI: 10.1158/1940-6207.PREV-11-CN02-02

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract CN02-02: Ovarian cancer GWAS: Path from risk assessment to prevention?
Thomas A. Sellers
Cancer Prev Res October 1 2011 (4) (10 Supplement) CN02-02; DOI: 10.1158/1940-6207.PREV-11-CN02-02
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Genetics, Epigenetics, and Genomics

  • Abstract SS01-01: Using genomic technologies to improve cancer risk assessment
  • Abstract CN04-02: Tumor and genomic heterogeneity in breast cancer prevention
Show more Genetics, Epigenetics, and Genomics

Prevention of Gynecologic Cancers: Ovary, Uterine, and Cervix

  • Abstract CN02-03: Prevention of human papillomavirus-related malignancy in the post-vaccine era
Show more Prevention of Gynecologic Cancers: Ovary, Uterine, and Cervix

Prevention of Gynecologic Cancers: Ovary, Uterine, and Cervix: Oral Presentations - Invited Abstracts

  • Abstract CN02-03: Prevention of human papillomavirus-related malignancy in the post-vaccine era
  • Abstract CN02-02: Ovarian cancer GWAS: Path from risk assessment to prevention?
Show more Prevention of Gynecologic Cancers: Ovary, Uterine, and Cervix: Oral Presentations - Invited Abstracts
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement